Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders



Page Path
HOME > Search
1 "Anastasia N. Kaminioti"
Article category
Publication year
Case Report
Ventricular Bigeminy after Subcutaneous Administration of Apomorphine in a Patient with Refractory Parkinson’s Disease: A Case Report
Anastasia N. Kaminioti, Georgios T. Nikitas, Apostolos K. Terlis, Athanasios G. Manolis, Thomas Thomaides, Aggeliki N. Panousopoulou
J Mov Disord. 2013;6(1):9-12.
  • 30,913 View
  • 63 Download
  • 7 Crossref
AbstractAbstract PDF

Apomorphine is a well established treatment for the management of sudden, unexpected and refractory levodopa-induced “off” states in fluctuating Parkinson’s disease either as bolus injections or as continuous infusions. Incidents of atrial fibrillation associated with the administration of the drug have been reported in the past but no incidents of ventricular arrhythmias. We report a case of ventricular bigeminy recorded in a female patient after the administration of apomorphine.


Citations to this article as recorded by  
  • Parkinson's disease advanced therapies - A systematic review: More unanswered questions than guidance
    Luca Marsili, Matteo Bologna, Janis M. Miyasaki, Carlo Colosimo
    Parkinsonism & Related Disorders.2021; 83: 132.     CrossRef
  • Emerging Pharmacotherapies for Motor Symptoms in Parkinson’s Disease
    Mohammad Al Majali, Michael Sunnaa, Pratap Chand
    Journal of Geriatric Psychiatry and Neurology.2021; 34(4): 263.     CrossRef
  • Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients
    Martin Klietz, Stephan Greten, Florian Wegner, Günter U. Höglinger
    Drugs & Aging.2019; 36(6): 511.     CrossRef
  • Pharmacological Insights into the Use of Apomorphine in Parkinson’s Disease: Clinical Relevance
    Manon Auffret, Sophie Drapier, Marc Vérin
    Clinical Drug Investigation.2018; 38(4): 287.     CrossRef
  • Cardiac abnormalities in Parkinson’s disease and Parkinsonism
    Fulvio A. Scorza, Ana C. Fiorini, Carla A. Scorza, Josef Finsterer
    Journal of Clinical Neuroscience.2018; 53: 1.     CrossRef
  • Apomorphine en perfusion sous-cutanée continue dans la maladie de Parkinson : le point de vue pharmacologique
    M. Auffret, S. Drapier, M. Vérin, P. Sauleau
    Pratique Neurologique - FMC.2016; 7(1): 25.     CrossRef
  • Practical management of adverse events related to apomorphine therapy
    Roongroj Bhidayasiri, Pedro J. Garcia Ruiz, Tove Henriksen
    Parkinsonism & Related Disorders.2016;[Epub]     CrossRef

JMD : Journal of Movement Disorders Twitter